Attila, if we assume the decision is entirely up to the MHRA and they don't care about Northwest Bio’s finances, why wait until May 21st if they’ve already made a choice? The only other explanation is that Northwest is intentionally dragging its feet on its recent RFIs. Otherwise, how does this delay make any sense?
Well GZ who I speak with regularly must be totally in the dark of the happenings with MHRA approval, if LP is indeed slow walking the approval, he has been adamant about how long MHRA is taking on a decision and completely frustrated like the rest of us.
Market Data 
Markets 
AI
